Filling the need for trusted information on national health issues…

Trending on kff Subsidies Marketplaces Enrollment

Aeras, IDRI Partner To Develop Novel TB Vaccine

In a guest post on the Global Health Technologies Coalition’s “Breakthroughs” blog, Jamie Elizabeth Rosen, media and communications manager at Aeras, interviews Steven Reed, founder, president, and chief scientific officer of the Infectious Disease Research Institute (IDRI), “a 120-person non-profit biotech committed to applying innovative science to the research and development of products to prevent, detect, and treat infectious diseases of poverty.” Aeras, “a non-profit biotech focused on developing vaccines against TB,” has partnered with IDRI to develop a novel tuberculosis (TB) vaccine candidate, Rosen notes and summarizes Reed’s responses to questions regarding TB vaccine development (Taylor, 5/29).